BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25856785)

  • 1. Visit-to-visit variability and seasonal variation in blood pressure: Combination of Antihypertensive Therapy in the Elderly, Multicenter Investigation (CAMUI) Trial subanalysis.
    Sato N; Saijo Y; Sasagawa Y; Morimoto H; Takeuchi T; Sano H; Koyama S; Takehara N; Morita K; Sumitomo K; Maruyama J; Kikuchi K; Hasebe N;
    Clin Exp Hypertens; 2015; 37(5):411-9. PubMed ID: 25856785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and effects on lipid metabolism of combination treatment with losartan + hydrochlorothiazide versus losartan + amlodipine: a 48-week prospective, multicenter, randomized, open-label trial.
    Nishiwaki M; Hosoai H; Ikewaki K; Ayaori M; Yamashita T; Shige H; Higashi K; Nashida Y; Shimizu S; Kijima F; Yokoyama M; Nakamura H;
    Clin Ther; 2013 Apr; 35(4):461-73. PubMed ID: 23490288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of antihypertensive therapy in the elderly, multicenter investigation (CAMUI) trial: results after 1 year.
    Sato N; Saijo Y; Sasagawa Y; Morimoto H; Takeuchi T; Sano H; Koyama S; Takehara N; Morita K; Sumitomo K; Maruyama J; Kikuchi K; Hasebe N;
    J Hypertens; 2013 Jun; 31(6):1245-55. PubMed ID: 23492647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of the losartan-hydrochlorothiazide combination tablet in patients with hypertension uncontrolled by angiotensin II receptor antagonist therapy: the Aichi Research on Combination therapy for Hypertension (ARCH) Study.
    Maeda K; Adachi M; Kinoshita A; Koh N; Miura Y; Murohara T
    Intern Med; 2012; 51(10):1167-75. PubMed ID: 22687785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Diuretic or Calcium-Channel Blocker Plus Angiotensin-Receptor Blocker on Diastolic Function in Hypertensive Patients.
    Toh N; Ishii K; Kihara H; Iwakura K; Watanabe H; Yoshikawa J; Ito H;
    Circ J; 2016; 80(2):426-34. PubMed ID: 26725762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy of angiotensin II receptor blocker and calcium channel blocker exerts pleiotropic therapeutic effects in addition to blood pressure lowering: amlodipine and candesartan trial in Yokohama (ACTY).
    Maeda A; Tamura K; Kanaoka T; Ohsawa M; Haku S; Azushima K; Dejima T; Wakui H; Yanagi M; Okano Y; Fujikawa T; Toya Y; Mizushima S; Tochikubo O; Umemura S
    Clin Exp Hypertens; 2012; 34(4):249-57. PubMed ID: 22571446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure response with fixed-dose combination therapy: comparing hydrochlorothiazide with amlodipine through individual-level meta-analysis.
    Agarwal R; Weir MR
    J Hypertens; 2013 Aug; 31(8):1692-701. PubMed ID: 23697963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Losartan/hydrochlorothiazide combination therapy surpasses high-dose angiotensin receptor blocker in the reduction of morning home blood pressure in patients with morning hypertension.
    Hanayama Y; Uchida HA; Nakamura Y; Makino H
    Acta Med Okayama; 2012; 66(6):449-59. PubMed ID: 23254579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visit-to-Visit Variability and Seasonal Variation in Blood Pressure With Single-Pill Fixed-Dose Combinations of Angiotensin II Receptor Blocker/Calcium Channel Blocker and Angiotensin II Receptor Blocker/Diuretic in Hypertensive Patients.
    Shiga Y; Miura S; Adachi S; Suematsu Y; Sugihara M; Iwata A; Yahiro E; Nishikawa H; Ogawa M; Saku K
    J Clin Med Res; 2015 Oct; 7(10):802-6. PubMed ID: 26346540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study.
    Ma L; Wang W; Zhao Y; Zhang Y; Deng Q; Liu M; Sun H; Wang J; Liu L
    Am J Cardiovasc Drugs; 2012 Apr; 12(2):137-42. PubMed ID: 22329591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Possibilities of rational combination antihypertensive therapy: results of HEMERA international clinical trial].
    Chazova IE; Martyniuk TV
    Ter Arkh; 2013; 85(10):10-22. PubMed ID: 24437213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective direct comparison of antihypertensive effect and safety between high-dose amlodipine or indapamide in hypertensive patients uncontrolled by standard doses of angiotensin receptor blockers and amlodipine.
    Okamura K; Shirai K; Totake N; Okuda T; Urata H
    Clin Exp Hypertens; 2018; 40(2):99-106. PubMed ID: 28692311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-grade inflammation and ambulatory blood pressure response to antihypertensive treatment: the ALPHABET study.
    Fukutomi M; Hoshide S; Eguchi K; Watanabe T; Kario K
    Am J Hypertens; 2013 Jun; 26(6):784-92. PubMed ID: 23446957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective randomized study of the tolerability and efficacy of combination therapy for hypertensive chronic kidney disease: results of the PROTECT-CKD study.
    Hayashi M; Uchida S; Kawamura T; Kuwahara M; Nangaku M; Iino Y;
    Clin Exp Nephrol; 2015 Oct; 19(5):925-32. PubMed ID: 25680887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
    Neutel J; Shojaee A; Maa JF
    Adv Ther; 2012 Jun; 29(6):508-23. PubMed ID: 22773358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choice of Antihypertensive Combination Therapy Based on Daily Salt Intake.
    Toyoda S; Inami S; Kato T; Tsukada K; Nakamoto A; Kikegawa Y; Suzuki A; Anraku Y; Node K; Inoue T
    Am J Med Sci; 2015 Sep; 350(3):160-6. PubMed ID: 26196407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On the way to achieve hypertension treatment goals: results of the open observational program AESCULAP (exforge--clinical safety and efficiency of using a double combination of antihypertensive drugs in patients with uncontrolled blood pressure)].
    Chazova IE; Martynyuk TV
    Ter Arkh; 2013; 85(9):35-45. PubMed ID: 24261228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
    Petrella R; Michailidis P
    Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double-Blind Randomized Controlled Trial.
    MacDonald TM; Williams B; Webb DJ; Morant S; Caulfield M; Cruickshank JK; Ford I; Sever P; Mackenzie IS; Padmanabhan S; McCann GP; Salsbury J; McInnes G; Brown MJ;
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29151036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.